Detalhe da pesquisa
1.
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.
Future Oncol
; 19(24): 1695-1708, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37605877
2.
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors.
Int J Mol Sci
; 21(18)2020 09 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32899866
3.
Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
Int J Mol Sci
; 21(17)2020 09 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32899139
4.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 474-485, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29482983
5.
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
Oncologist
; 22(6): 648-654, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28432226
6.
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis.
Front Oncol
; 14: 1362641, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38595817
7.
An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients.
In Vivo
; 37(4): 1445-1449, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37369460
8.
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice.
Front Oncol
; 12: 1032166, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36387212
9.
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.
BMC Cancer
; 11: 75, 2011 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-21324184
10.
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial.
Eur J Cancer
; 118: 178-186, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31164265
11.
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.
Crit Rev Oncol Hematol
; 66(2): 171-80, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18160303
12.
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.
Mol Clin Oncol
; 9(3): 255-263, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30155246
13.
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.
BMC Cancer
; 7: 50, 2007 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-17374151
14.
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design.
J Clin Oncol
; 20(20): 4150-9, 2002 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12377958
15.
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience.
BMC Cancer
; 5: 30, 2005 Mar 24.
Artigo
Inglês
| MEDLINE | ID: mdl-15790416
16.
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.
Biomed Res Int
; 2015: 158682, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26504780
17.
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
J Clin Oncol
; 33(8): 910-5, 2015 Mar 10.
Artigo
Inglês
| MEDLINE | ID: mdl-25624439
18.
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.
J Clin Oncol
; 27(19): 3192-7, 2009 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19380451
19.
Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.
J Clin Oncol
; 26(2): 264-70, 2008 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-18086795
20.
First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatment.
Oncologist
; 12(11): 1288-98, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18055848